Letrozole and Facial paresis - a phase IV clinical study of FDA data

Summary:

Facial paresis is found among people who take Letrozole, especially for people who are female, 40-49 old.

The phase IV clinical study analyzes which people take Letrozole and have Facial paresis. It is created by eHealthMe based on reports of 39,784 people who have side effects when taking Letrozole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

39,784 people reported to have side effects when taking Letrozole.
Among them, 7 people (0.02%) have Facial paresis.


What is Letrozole?

Letrozole has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 40,306 Letrozole users for its effectiveness, alternative drugs and more.

What is Facial paresis?

Facial paresis (weakness in facial muscle movement) is found to be associated with 1,251 drugs and 842 conditions by eHealthMe.

Number of Letrozole and Facial paresis reports submitted per year:

Could Letrozole cause Facial paresis?

Gender of people who have Facial paresis when taking Letrozole *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Facial paresis when taking Letrozole *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Letrozole *:

  1. Tegretol: 7 people, 100.00%
  2. Palbociclib: 7 people, 100.00%
  3. Metoprolol Tartrate: 1 person, 14.29%
  4. Docetaxel: 1 person, 14.29%
  5. Cyclophosphamide: 1 person, 14.29%
  6. Carboplatin: 1 person, 14.29%

Common side effects people have besides Facial paresis *:

  1. Loss Of Consciousness: 7 people, 100.00%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 7 people, 100.00%
  3. Weight Decreased: 5 people, 71.43%
  4. Thrombocytopenia (decrease of platelets in blood): 5 people, 71.43%
  5. Speech Disorder: 5 people, 71.43%
  6. Nausea (feeling of having an urge to vomit): 5 people, 71.43%
  7. Gait Disturbance: 5 people, 71.43%
  8. Metastases To Central Nervous System (cancer spreads to central nervous system): 4 people, 57.14%
  9. Malignant Neoplasm Progression (cancer tumour came back): 3 people, 42.86%
  10. Weakness: 1 person, 14.29%

Common conditions people have *:

  1. Metastases To Central Nervous System (cancer spreads to central nervous system): 5 people, 71.43%

* Approximation only. Some reports may have incomplete information.

Do you take Letrozole and have Facial paresis?

Check whether Facial paresis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Facial paresis and when was it recovered:

Expand to all the drugs that have ingredients of letrozole:

Alternative drugs to, pros and cons of Letrozole:

Common Letrozole side effects:

Browse all side effects of Letrozole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Facial paresis treatments and more:

COVID vaccines that are related to Facial paresis:

Common drugs associated with Facial paresis:

All the drugs that are associated with Facial paresis:

Common conditions associated with Facial paresis:

All the conditions that are associated with Facial paresis:

How the study uses the data?

The study uses data from the FDA. It is based on letrozole (the active ingredients of Letrozole) and Letrozole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: